Skip to content

Mescaline: all studies

Page 57 of 97: studies 561 to 570 of 963, newest first. Back to the mescaline overview

Research

Contribution of Magical-Religious Practices to Ethnobotanical Knowledge in Peru

January 9, 2026 José Mostacero-León, Jesús Manuel Charcape Ravelo, Anthony Jordan de la Cruz Castillo et al.

The research highlights the fundamental role of magical-religious practices in the preservation, use, and transmission of ethnobotanical knowledge in Peru. These practices, deeply rooted in the Andean-Amazonian worldview, manifest themselves through the symbolic and therapeutic use of sacred plants, contributing to the continuity of the cultural and spiritual identities of indigenous...

DOI: 10.1201/9781003500926-4 (opens in new tab) Shamanism Ethnobotany Indigenous Traditional knowledge +5

Attitudes Toward Psychedelics and Psychedelic-Assisted Therapy (PAT) Among Mental Health Professionals in Poland and Their Associations with Cognitive, Epistemic, and Existential Factors

Open Mind 2026 Katarzyna Korsak, Daniel Pankowski, Paweł Holas preprint

The clinical use of psychedelic substances and Psychedelic-Assisted Therapy (PAT) is an area of growing interest that also raises significant social concerns and controversy. Despite existing legal restrictions, empirical research on substances such as psilocybin, mescaline, MDMA, LSD, DMT, and ibogaine has been developing, particularly in the treatment of conditions such as treatment-resistant...

Blueprint for an Anarchist Sunrise: How to Dream in a Pragmatic Way

2026 Uwe Rasch

AbstractThis chapter first traces the most relevant biographical events of Huxley’s final years from the 1950s to 1963. While the previous chapter focused on his continued warnings of the trends that curb freedom and democracy, this chapter instead focuses on his campaign to protect and increase individual freedom and exploit its creative and ethical potentialities. In 1953, Huxley first tried...

DOI: 10.1007/978-3-031-57609-6_6 (opens in new tab) Blueprint Politics Dream Utopia +10

Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studies

Repository for Publications and Research Data 2026 Kurt Stocker, Matthias Hartmann, Frederick S. Barrett et al.

Mystical dynamics-the notion that mystical oneness may unfold involving ego disintegration, renewal, and luminous light-has been discussed anecdotally by psychedelic researchers and therapists but has not yet been empirically examined in controlled settings. This study investigated the occurrence and dose-dependency of mystical dynamics in healthy participants after administration of...

DOI: 10.3929/ethz-c-000798382 (opens in new tab) Mysticism Experiential learning Religious experience Dynamics music +2

Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy.

Current Topics in Behavioral Neurosciences 2026 Anna-Lena Bröcker, Tomislav Majić, Christiane Montag 2 citations

Psychotic symptoms are uncommon and non-specific adverse effects of classic (serotonergic) psychedelics such as lysergic acid diethylamide (LSD), psilocybin, and mescaline. They can emerge during the acute phase of psychedelic drug effects, persist into the subacute ("afterglow") period, or, in rare cases, develop into long-term psychotic illness. Across all three scenarios, the symptoms can be...

Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling.

Therapeutic advances in drug safety 2026 Ovie Martin Albert, Alexander Arthur

Psychedelic and psychedelic-adjacent substances, including 3,4-methylenedioxymethamphetamine (MDMA) and classic serotonergic hallucinogens, are undergoing renewed therapeutic investigation and remain in non-medical use. Inadvertent exposure during early, unrecognized pregnancy is clinically plausible, yet pregnancy-specific safety evidence is limited. To map and synthesize the extent,...

DOI: 10.1177/20420986261436104 (opens in new tab) Full text (opens in new tab) Lysergic acid diethylamide 3,4-methylenedioxymethamphetamine Congenital anomalies Hallucinogens +2

Natural Hallucinogens in Clinical Studies: A Review of Therapeutic Efficacy and Methodological Limitations

Farmacja Polska December 30, 2025 Ewa Niedzielska-Andres, Angelika Ziaja, Stanisław Zielinski et al.

Przedmiot badań: W ostatnich latach obserwuje się rosnące zainteresowanie wykorzystaniem naturalnych halucynogenów w leczeniu zaburzeń psychicznych, uzależnień czy bólu. Substancje takie jak psylocybina, ayahuasca, ibogaina czy meskalina poddawane są ocenie w badaniach klinicznych, które wskazują na ich potencjał terapeutyczny, zwłaszcza w leczeniu depresji lekoopornej, zespołu stresu...

DOI: 10.32383/farmpol/215392 (opens in new tab) Gynecology Traditional medicine Theology

Psychedelics in Psychiatry: New Treatment Paradigms or Addictive Treatment Strategies? A Narrative Review

Pharmaceutical Science December 9, 2025 Marco Otto Toscano, Serena Chiara Civardi, Federico Durbano

Scientific interest in psychedelics, documented since the nineteenth century, has recently resurged after decades of prohibition. Contemporary research highlights their therapeutic potential in treatment-resistant psychiatric disorders, alongside their heuristic value for studying brain networks and consciousness. This chapter reviews the historical trajectory, traditional uses, mechanisms of...

DOI: 10.5772/intechopen.1014070 (opens in new tab) Enthusiasm Narrative review Perspective graphical Ambivalence +7

Micro-Messiahs: When Psychedelics and Politics Meet

December 2, 2025 Leor Roseman

The recent mainstreaming of psychedelics has distanced itself from the countercultural image of the past, yet the question of whether psychedelics are political remains pressing. What happens when psychedelics meet politics?On one hand lies the politics of the unitive mystical experience: harmony, beyond good & evil, beyond space & time, and with love to all. Studying ayahuasca groups of...

Psychedelics for the Treatment of Substance Use Disorders

SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice December 1, 2025 Johannes Klaus, Fritz Schneider, Rena Schaletzky et al.

Abstract: Background: Psychedelic-assisted therapy is increasingly being explored as potential treatment for substance use disorders (SUDs). While multiple systematic reviews and meta-analyses have examined this topic, the efficacy, method­ological quality, and overlap of the existing evidence base remain unclear. Methods: We conducted an umbrella review of systematic reviews and meta-analyses...